These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 18603076)
21. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients. Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853 [TBL] [Abstract][Full Text] [Related]
22. Autoantibody biomarker opens a new gateway for cancer diagnosis. Nesterova M; Johnson N; Cheadle C; Cho-Chung YS Biochim Biophys Acta; 2006 Apr; 1762(4):398-403. PubMed ID: 16483750 [TBL] [Abstract][Full Text] [Related]
23. Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma. Zhang JB; Cao M; Chen J; Ye SR; Xie K; He X; Ma XL; Zhang J; Yie SM Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):276-284. PubMed ID: 29170084 [TBL] [Abstract][Full Text] [Related]
24. Serum Glycoprotein Biomarker Discovery and Qualification Pipeline Reveals Novel Diagnostic Biomarker Candidates for Esophageal Adenocarcinoma. Shah AK; Cao KA; Choi E; Chen D; Gautier B; Nancarrow D; Whiteman DC; Saunders NA; Barbour AP; Joshi V; Hill MM Mol Cell Proteomics; 2015 Nov; 14(11):3023-39. PubMed ID: 26404905 [TBL] [Abstract][Full Text] [Related]
25. Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1. Türeci O; Mack U; Luxemburger U; Heinen H; Krummenauer F; Sester M; Sester U; Sybrecht GW; Sahin U Cancer Lett; 2006 May; 236(1):64-71. PubMed ID: 15992994 [TBL] [Abstract][Full Text] [Related]
26. Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer: A Phase III Study. Maddalo G; Fassan M; Cardin R; Piciocchi M; Marafatto F; Rugge M; Zaninotto G; Pozzan C; Castoro C; Ruol A; Biasiolo A; Farinati F J Clin Gastroenterol; 2018; 52(5):401-406. PubMed ID: 28422774 [TBL] [Abstract][Full Text] [Related]
27. Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer. Sun H; Shi JX; Zhang HF; Xing MT; Li P; Dai LP; Luo CL; Wang X; Wang P; Ye H; Li LX; Zhang JY Tumour Biol; 2017 Jun; 39(6):1010428317699132. PubMed ID: 28618923 [TBL] [Abstract][Full Text] [Related]
28. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus. Chiam K; Mayne GC; Wang T; Watson DI; Irvine TS; Bright T; Smith LT; Ball IA; Bowen JM; Keefe DM; Thompson SK; Hussey DJ World J Gastroenterol; 2020 May; 26(20):2570-2583. PubMed ID: 32523312 [TBL] [Abstract][Full Text] [Related]
29. Autoantibody signature in hepatocellular carcinoma using seromics. Zhang S; Liu Y; Chen J; Shu H; Shen S; Li Y; Lu X; Cao X; Dong L; Shi J; Cao Y; Wang X; Zhou J; Liu Y; Chen L; Fan J; Ding G; Gao Q J Hematol Oncol; 2020 Jul; 13(1):85. PubMed ID: 32616055 [TBL] [Abstract][Full Text] [Related]
30. The identification of phosphoglycerate kinase-1 and histone H4 autoantibodies in pancreatic cancer patient serum using a natural protein microarray. Patwa TH; Li C; Poisson LM; Kim HY; Pal M; Ghosh D; Simeone DM; Lubman DM Electrophoresis; 2009 Jun; 30(12):2215-26. PubMed ID: 19582723 [TBL] [Abstract][Full Text] [Related]
31. Tumor-associated autoantibody signature for the early detection of gastric cancer. Zayakin P; Ancāns G; Siliņa K; Meistere I; Kalniņa Z; Andrejeva D; Endzeliņš E; Ivanova L; Pismennaja A; Ruskule A; Doniņa S; Wex T; Malfertheiner P; Leja M; Linē A Int J Cancer; 2013 Jan; 132(1):137-47. PubMed ID: 22684876 [TBL] [Abstract][Full Text] [Related]
32. A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection. Dumstrei K; Chen H; Brenner H Oncotarget; 2016 Mar; 7(10):11151-64. PubMed ID: 26840568 [TBL] [Abstract][Full Text] [Related]
33. Multiple serological biomarkers for colorectal cancer detection. Chan CC; Fan CW; Kuo YB; Chen YH; Chang PY; Chen KT; Hung RP; Chan EC Int J Cancer; 2010 Apr; 126(7):1683-90. PubMed ID: 19795454 [TBL] [Abstract][Full Text] [Related]
34. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer. Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459 [TBL] [Abstract][Full Text] [Related]
35. Epitope presentation is an important determinant of the utility of antigens identified from protein arrays in the development of autoantibody diagnostic assays. Murphy MA; O'Connell DJ; O'Kane SL; O'Brien JK; O'Toole S; Martin C; Sheils O; O'Leary JJ; Cahill DJ J Proteomics; 2012 Aug; 75(15):4668-75. PubMed ID: 22415278 [TBL] [Abstract][Full Text] [Related]
36. The alcohol dehydrogenase isoenzyme (ADH IV) as a candidate tumour marker of esophageal cancer. Jelski W; Laniewska-Dunaj M; Niklinski J; Kozłowski M; Laudanski J; Szmitkowski M Acta Biochim Pol; 2013; 60(3):489-93. PubMed ID: 24051444 [TBL] [Abstract][Full Text] [Related]
37. Anti-heat shock protein autoantibody profiling in breast cancer using customized protein microarray. Shi L; Gehin T; Chevolot Y; Souteyrand E; Mangé A; Solassol J; Laurenceau E Anal Bioanal Chem; 2016 Feb; 408(5):1497-506. PubMed ID: 26715250 [TBL] [Abstract][Full Text] [Related]
38. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer]. Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769 [TBL] [Abstract][Full Text] [Related]
39. The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma. Li Z; Xu H; Yu J; Liu C; Zheng C; Zeng R; Xu L; Li E; Peng Y; Xu Y Cancer Control; 2021; 28():10732748211004883. PubMed ID: 33926265 [TBL] [Abstract][Full Text] [Related]
40. Elevated serum synuclein-gamma in patients with gastrointestinal and esophageal carcinomas. Liu C; Ma H; Qu L; Wu J; Meng L; Shou C Hepatogastroenterology; 2012 Oct; 59(119):2222-7. PubMed ID: 22440249 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]